InsuLine Medical Ltd (INSL):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:InsuLine Medical Ltd (INSL) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7293
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イスラエル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
InsuLine Medical Ltd (InsuLine Medical) is a medical device company that develops, manufactures and markets device which enables patients on intensive insulin therapy. The company offers products such as InsuPad and InsuPatch which are designed to improve the current meal-time insulin therapy. Its InsuPad is a patch for syringes and insulin pens including disposable injection window part, and a reusable rechargeable control unit, using the injection site treatment and stabilization technology; and InsuPatch which is used as a catheter and pump holder for pumps. InsuLine Medical also offers disposable devices that are used for treating the point of injection with heat. The company markets its products through online and a network of distributors in the US, Canada, Israel and Germany. InsuLine Medical is headquartered in Petah Tikva, Israel.

InsuLine Medical Ltd (INSL) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
InsuLine Medical Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
InsuLine Medical Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
InsuLine Medical Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
InsuLine Medical Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
InsuLine Medical Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
InsuLine Medical Ltd, Medical Equipment, Deal Details 10
Venture Financing 10
InsuLine Medical to Raise Funds in Financing Round 10
Equity Offering 11
InsuLine Medical Announces Rights Offering Of Shares For US$2.8 Million 11
InsuLine Medical Completes Private Placement Of Units For US$2.2 Million 12
InsuLine Medical Ltd – Key Competitors 13
InsuLine Medical Ltd – Key Employees 14
InsuLine Medical Ltd – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
InsuLine Medical Ltd, Medical Equipment, Key Facts, 2017 2
InsuLine Medical Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
InsuLine Medical Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
InsuLine Medical Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
InsuLine Medical Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
InsuLine Medical Ltd, Deals By Market, 2012 to YTD 2018 8
InsuLine Medical Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
InsuLine Medical to Raise Funds in Financing Round 10
InsuLine Medical Announces Rights Offering Of Shares For US$2.8 Million 11
InsuLine Medical Completes Private Placement Of Units For US$2.2 Million 12
InsuLine Medical Ltd, Key Competitors 13
InsuLine Medical Ltd, Key Employees 14

List of Figures
InsuLine Medical Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
InsuLine Medical Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
InsuLine Medical Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
InsuLine Medical Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
InsuLine Medical Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
InsuLine Medical Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
InsuLine Medical Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
InsuLine Medical Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[InsuLine Medical Ltd (INSL):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Batu Biologics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Batu Biologics Inc (Batu Biologics) is an immuno-oncology company. The company offers development and commercialization of novel therapies that target the Achilles Heel of cancer: the tumor blood vessels. Its lead product ValloVax is a cellular anti-angiogenic cancer vaccine that is develope …
  • Euroclear Plc
    Euroclear Plc - Strategy, SWOT and Corporate Finance Report Summary Euroclear Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • WESCO International, Inc.:企業の戦略・SWOT・財務分析
    WESCO International, Inc. - Strategy, SWOT and Corporate Finance Report Summary WESCO International, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Woori Bank:戦略・SWOT・企業財務分析
    Woori Bank - Strategy, SWOT and Corporate Finance Report Summary Woori Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • H3 Biomedicine Inc-製薬・医療分野:企業M&A・提携分析
    Summary H3 Biomedicine Inc (H3 Biomedicine), a subsidiary of Eisai Co Ltd is a biopharmaceutical company that offers therapies. The company concentrates on discovery and early development of novel, targeted anti-cancer compounds. Its products include small-molecule drugs that are developed by utiliz …
  • Rolta India Ltd (ROLTA):企業の財務・戦略的SWOT分析
    Rolta India Ltd (ROLTA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Abbott Vascular Inc:医療機器:M&Aディール及び事業提携情報
    Summary Abbott Vascular Inc (Abbott Vascular), formerly Perclose, Inc., a subsidiary of Abbott Laboratories, is a medical device company that develops manufactures and markets cardiovascular devices. The company offers coronary intervention, peripheral intervention, and structural heart products. It …
  • Express Scripts Holding Co (ESRX)-製薬・医療分野:企業M&A・提携分析
    Summary Express Scripts Holding Company (Express Scripts) is a pharmacy benefit management (PBM) company. It provides integrated pharmacy-benefit management services such as home delivery pharmacy services, specialty benefit management, network-pharmacy claims processing, formulary management, and m …
  • Heinzel Holding GmbH:企業の戦略的SWOT分析
    Heinzel Holding GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • SINTX Technologies Inc (SINT)
    SINTX Technologies Inc (SINT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Streamline Health Solutions Inc (STRM):医療機器:M&Aディール及び事業提携情報
    Summary Streamline Health Solutions Inc (Streamline Health) is a medical technology company that offers patient engagement and SaaS-based solutions. The company provides solutions including HIM, patient engagement, patient care, coding and CDI, and financial management solutions. It offers its patie …
  • Recordati S.p.A.:企業の戦略・SWOT・財務分析
    Recordati S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Recordati S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • The Federal Reserve System:企業の戦略的SWOT分析
    The Federal Reserve System - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Promethera Biosciences SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Promethera Biosciences SA (Promethera) is a developer of cell therapy products for the treatment of liver diseases. The company provides products which are developed on its proprietary progenitor cell type. It offers products such as promethera hepastem and promethera hepascreen, among other …
  • Dai Nippon Printing Co., Ltd.:企業の戦略・SWOT・財務情報
    Dai Nippon Printing Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Dai Nippon Printing Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • RespireRx Pharmaceuticals Inc (RSPI):製薬・医療:M&Aディール及び事業提携情報
    Summary RespireRx Pharmaceuticals Inc (RespireRx), formerly Cortex Pharmaceuticals, Inc., focuses on the discovery, development and commercialization of innovative products for the treatment of various respiratory disorders. It has two drug platforms, each with a clinical stage compound directed at …
  • Itausa – Investimentos Itau S.A.:企業の戦略・SWOT・財務情報
    Itausa - Investimentos Itau S.A. - Strategy, SWOT and Corporate Finance Report Summary Itausa - Investimentos Itau S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Cortec GmbH:企業の製品パイプライン分析2018
    Summary Cortec GmbH (Cortec), a subsidiary of Iron Force Industrial Co Ltd, is a medical engineering company that develops neurons technology platform for the measurement and stimulation of brain activity. The company develops implants that serve as a direct interface between brain and technology. I …
  • Viridian Energy Supply Ltd.:企業の戦略的SWOT分析
    Viridian Energy Supply Ltd. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Exosomics Siena SpA:企業の製品パイプライン分析2018
    Summary Exosomics Siena SpA (Exosomics Siena) is a biotechnology company that offers research and development services. The company provides services such as contract research, collaborative project management, lead development and technological services. It offers technological services such as sam …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆